Amyris Inc (fka AMRSQ)

[finesand]

you should clean your ears a bit: 'double or better' even the CFO said, while low-balling expectations to not create another Melo disaster.

Performance compared w/ current MCAP assuming 64M OS fully diluted -> this stock is very cheap right now.

Recovery should indeed match last purchase price $4.26, equaling $14 pre-dilution or around $1 pre-RS.

When you realize the progress being made incl. production facilities and many not-mentioned items .. you will know what you have bought.

Hint: High overall revenue w/o much collaboration cash, while margins are low due to pending profit shares payout with higher margins. Also: DSM impact 2018-2019.